This article examines the key differences between primary and secondary screening in drug discovery, detailing how primary ...
Homozygous but not heterozygous loss of Pten in sporadic mouse models of SHH-medulloblastoma greatly accelerates tumor formation, not metastasis, through increased survival of differentiated cells and ...
Modality-agnostic decoders leverage modality-invariant representations in human subjects' brain activity to predict stimuli irrespective of their modality (image, text, mental imagery).
At ABBYY Ascend 2026, CEO Ulf Persson unveils how the company's Document AI platform is evolving to meet current needs.